This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Have your got your EU MDR PMS & Vigilance strategy in place? 1 more year. 1 more chance.

Regulatory Insights On PSURs. Create Robust PMS Plans. Updates On Manufacturer's Incident Reports

Overcome The Obstacles With Notified Body Advice And Practical Industry Examples

Post Market Surveillance & Vigilance

All You Need To Know
  • Join Notified Bodies NSAI, IMQ and TÜV SÜD to discuss their requirements for Post Market Surveillance
  • Novartis were the first company to get a CE mark for their Concept1 inhaler under the EU MDR. Hear about their first 9 months of PMS.
  • Want to EU MDR proof your PMS plan? Gain leading insights from Abbott and TÜV SÜD 
  • Hear the latest on Proactive PMS and Vigilance strategies with BioTronik & Novocure  
  • Get up to date perspectives on Periodic Safety Update Reports (PSURs) with feedback from leading Manufacturers 
Post Market Reporting
  • Hear the latest on how the first 6 months of Manufacturer Incident Reporting (MIR) have gone
  • Edwards Life Sciences and Telefex provide practical insights on Serious Incident Reporting 
  • Update your strategies to ensure your trend reporting, vigilance and compliant system is MDR ready with Stryker, Resmed and NSF
  • How can real world evidence help with Post Market Surveillance? Get the latest information.
  • Benefit from a joint session with the Clinical Evaluations & Investigations audience: Learn how to streamline clinical processes and create PMCFs
Elsewhere At The MedTech Summit..

Take a look at the 8 other MedTech Summit conference tracks to see what else is on the agenda for you:

  • Shine a light on Post Market Safety Reporting requirements for combination products in our Drug Device Combination Products track 
  • Be Prepared for China's increased focus on Post Market Surveillance with speakers from NPMA in the Medical Device Regulatory Affairs in Global Markets track
  • Join our EU Medical Device Regulation track to get updates, hear first-hand experiences and benchmark EU MDR implementation with your peers, with direct feedback from Competent Authority, Notified Body and industry representatives
See The Full MedTech Summit Agenda